Slow and steady seems to be the name of the game in the main personal injury lawsuit against DePuy Orthopaedics, a division of New Jersey company Johnson & Johnson, over its faulty artificial hip replacement products.
According to a recently released document, New Jersey company Johnson & Johnson began taking action to phase out the use of its metal-on-metal artificial hips just weeks after the receiving a letter from U.S. Food and Drug Administration. In that letter, the agency reportedly turned down Johnson's application to sell the medical product in the United States, and told the company to submit additional safety data if it wanted to pursue the application.
After a string of product recalls and products liability lawsuits, the chief executive officer of Johnson & Johnson is reportedly stepping down from his position later this spring. Although the New Jersey company's revenue has doubled in the past decade, the many product recalls in recent years have reportedly cost Johnson & Johnson more than $1 billion, as well as the serious hits to its public image and consumers' trust.
Last week, we wrote that the U.S. Food and Drug Administration had ordered additional research into the vaginal mesh products that have caused injury and even death to women throughout the country.
Earlier this week, we wrote about the recent influx of product liability lawsuits against New Jersey-based Johnson & Johnson regarding its vaginal mesh implant products, which have resulted in injury and death in hundreds of women throughout the country. The vaginal mesh suits are not the only litigation facing Johnson & Johnson at this time. The company is also defending itself against a growing class action products liability lawsuit after "mechanical failure" forced the recall of hundreds of artificial joints.
Later this week, the U.S. Senate Commerce Committee is scheduled to hear a bill which, if passed, will significantly increase the potential fines to automakers who delay automobile recalls for any reason. The bill also aims to toughen safety requirements for car manufacturers and commercial bus companies in the wake of several fatal car and bus accidents that have taken place in recent months.
Recently, the J.M. Smucker Co. announced that it was instituting a recall of more than 3,000 jars of its Smucker's Natural Peanut Butter Chunky product amidst concerns that the peanut butter was tainted with salmonella. If consumed, the salmonella bacteria found in unsafe foods causes fever, cramps, and diarrhea which can persist for several days and lead to hospitalization, lasting injury and death. Smucker claims that it has received no reports of illnesses as a result of the salmonella contamination.
Honda recently announced a worldwide recall of more than 1 million cars from two model lines in order to fix potential electrical problems and a software malfunctions in the vehicles. The recall is the second of its kind in a month: in early August, the automaker recalled about 1.5 million vehicles after learning of design defects in the vehicles' transmissions.
In what experts are calling one of the largest meat recalls in U.S. history, meat producer Cargill has recalled approximately 36 million pounds of ground turkey after more than 75 people reportedly contracted salmonella after consuming the affected products. In addition, the unsafe food is believed to be responsible for one death.
Although there has not been a significant number of cases in New Jersey and most states, with zero total deaths, the United States Food and Drug Administration (FDA) has announced a recall of four varieties of fresh, whole papayas after two separate shipments were found to contain the Salmonella Agona virus. According to FDA officials, the latest recall is solid evidence in support of its efforts to increase the sampling of papayas that are imported into the United States.